Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFESI with Pulsed RF for Chronic Lumbosacral Radicular Pain
NCT02930057Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of betamethasone in lumbosacral radiculopathy (2 arms), sponsored by Sheba Medical Center. Primary endpoints: Numerical Rating Scale (NRS) Pain Scores at 3 months and Quality of Life and Activities of Daily Living at 3 months. Status: unknown.
02
Drugs
betamethasone
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on NCT02930057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02930057.